Abstract
In a stable state children with Asperger’s and Kanner’s syndromes demonstrate a similar decrease in plasma norepinephrine. In the aggravated state, these changes become more expressed and are characterized by a decrease in plasma tyrosine, norepinephrine, normetanephrine, and by an increase in dopamine and homovanillic acid and a decrease in excretion of norepinephrine and an increase in excretion of homovanillic acid, epinephrine and 3-methoxy-4-hydroxyphenylglycol (MHPG). In the aggravated state children with Kanner’s syndrome were characterized by increased plasma MHPG, decreased excretion of tyrosine and increased expression of normetanephrine. The observed imbalance in dopamine and epinephrine/norepinephrine systems suggests importance of combined analysis of changes in catecholamines and their metabolites as the most informative approach in the study of the effect of autistic disorders.
Similar content being viewed by others
References
Robel, L., Rev. Prat., 2010, vol. 60, pp. 376–378.
Robel, L., Arch. Pediatr., 2009, vol. 16, pp. 1507–1512.
Levy, S.E., Mandell, D.S., and Schultz, R.T., Lancet, 2009, vol. 374, no. 9701, pp. 1627–1638.
Martineau, J., Barthölömy, C., Jouve, J., Muh, J.P., and Lelord, G., Dev. Med. Child. Neurol., 1992, vol. 34, pp. 593–603.
Minderaa, R. B., Anderson, G. M., Volkmar, F. R., Akkerhuis, G. W., and Cohen, D. J., Biol. Psychiatry, 1994, vol. 36, pp. 237–241.
Nagy, O., Kelemen, O., Benedek, G., Myers, C. E., Shohamy, D., Gluck, M.A., Köri, S.. J. Neural. Transm., 2007, vol. 114, pp. 607–612.
Previc, F.H., Med. Hypotheses, 2007, vol. 68, pp. 46–60.
Stern, L.M., Walker, M.K., Sawyer, M.G., Oades, R.D., Badcock, N.R., and Spence, J.G., J. Child. Psychol. Psychiatry, 1990, vol. 31, pp. 569–585.
Gillberg, C., Biol. Psychiatry, 1993, vol. 33, pp. 630–635.
Roberts, N. B., Higgins, G., and Sargazi, M., Clin. Chem. Lab. Med., 2010, vol. 48, pp. 81–87.
Barthelemy, C., Bruneau, N., Cottet-Eymard, J.M., Domenech-Jouve, J., Garreau, B., Lelord, G., Muh, J.P., and Peyrin, L., J. Autism Dev. Disord., 1988, vol. 18, pp. 583–591
Cook, E.H., Sinapse, 1990, vol. 6, pp. 292–308.
Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A., Meskal, A., Neels, H., Planken, M., Scharpe, S., Deboutte, D., Pison, G., Maes, M., Neuropsychopharmacology, 2000, vol. 136, pp. 275–283.
Eisenhofer, G., Kopin, I.J., and Goldstein, D.S., Pharmacol. Rev., 2004, vol. 38, pp. 331–349.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Gorina, L.S. Kolesnichenko, V.I. Mikhnovich, 2011, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Gorina, A.S., Kolesnichenko, L.S. & Mikhnovich, V.I. Catecholamine metabolism in children with Asperger’s and Kanner’s syndromes. Biochem. Moscow Suppl. Ser. B 5, 397–401 (2011). https://doi.org/10.1134/S1990750811040044
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750811040044